Today: 17 May 2026
Cisco stock jumps after Evercore lifts target to $175 as earnings near
4 February 2026
1 min read

Cisco stock jumps after Evercore lifts target to $175 as earnings near

New York, Feb 3, 2026, 19:41 EST — After-hours

  • Cisco shares rose 3.1% on Tuesday and remained steady in after-hours trading
  • Evercore ISI raised its price target to $175 and maintained an outperform rating
  • Investors are turning their attention to Cisco’s Feb. 11 earnings report as the next major catalyst

Cisco Systems shares surged Tuesday following a price target boost from Evercore ISI, providing a rare highlight amid a turbulent tech sector.

Cisco ended the day 3.1% higher, closing at $83.11. After-hours trading showed little movement, with most of the price action happening during the regular session.

This call is crucial as investors aim to distinguish the “AI winners” from firms vulnerable to disruption by emerging tools. Cisco is positioning itself more as the infrastructure supporting data-heavy workloads than just a pure software play.

U.S. stocks closed down, led by the Nasdaq which dropped 1.43%, amid concerns that AI might pressure profit margins in some software companies, Reuters reported.

On Feb. 3, Evercore ISI raised its price target for Cisco to $175 from $100, maintaining an outperform rating, MT Newswires reports.

Cisco set a firm date for its next big update. The company plans to release fiscal second-quarter results after markets close on Wednesday, Feb. 11, with a conference call scheduled for 4:30 p.m. ET.

At Cisco’s AI Summit Tuesday, CEO Chuck Robbins called 2026 “a turning point” for large-scale enterprise AI, highlighting a shift toward “agentic applications” — software agents that handle tasks with minimal human intervention. Network World

Jeetendra Patel, Cisco’s president and chief product officer, pointed to power, compute, and network bandwidth as key bottlenecks for AI expansion. He revealed that Cisco is investing “billions” to boost infrastructure capacity. Patel also noted that 70% of the AI products Cisco is working on incorporate AI-generated code. Network World

Investors will be watching to see if February’s figures reflect that message—not only in revenue but also in orders and guidance linked to AI-driven data center networking and security.

There’s a straightforward risk: if results or guidance on Feb. 11 disappoint, or if customers delay network upgrades further, the upbeat mood from Tuesday could quickly fade—tech sentiment remains fragile after all.

After a subdued after-hours session, focus turns to Wednesday’s trading and Cisco’s earnings report on Feb. 11, which should shed more light on demand trends and outlook for 2026.

Stock Market Today

  • Realty Income (O) Faces Mixed Valuation Signals After Solid Q1 and Raised AFFO Guidance
    May 17, 2026, 12:49 AM EDT. Realty Income (O) reported strong Q1 results and boosted its Adjusted Funds From Operations (AFFO) guidance, alongside its 671st monthly dividend, equity issuance, and buybacks. Despite these positive developments, its share price fell 6.1% over 30 days and 6.9% over 90 days. The stock trades at a high price-to-earnings (P/E) ratio of 50.9x, well above peer averages, suggesting valuation risk. However, a dividend-focused valuation model indicates the stock is 13.8% undervalued with a fair value of $70.93 compared to the current $61.12 share price. Investors should weigh steady dividend growth and operating margins against rising funding costs and regional revenue risks in Realty Income's western markets.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Dow Jones slips 167 points on AI disruption fears; Alphabet, Amazon earnings next
Previous Story

Dow Jones slips 167 points on AI disruption fears; Alphabet, Amazon earnings next

Accenture stock dives nearly 10% as AI disruption fears hit consulting — what ACN investors watch next
Next Story

Accenture stock dives nearly 10% as AI disruption fears hit consulting — what ACN investors watch next

Go toTop